Challenges in Translating iPSC Technology

Dr. James Wells moderates a panel discussion on the biggest challenges in translating organoid-based cell therapies and the steps needed to bring these technologies to market in an efficient and patient-first manner.

Publish Date: June 17, 2019 Views: 0

Explore Our Products

Mouse Pancreatic Organoids

Cryopreserved mouse pancreatic exocrine organoids for establishment of organoid cultures
PancreaCult™ Organoid Growth Medium (Mouse)

Cell culture medium for establishment and maintenance of mouse pancreatic exocrine organoids
STEMdiff™ Intestinal Organoid Kit

Serum-free medium kit for establishment and maintenance of human intestinal organoids from hPSCs
STEMdiff™ Dorsal Forebrain Organoid Differentiation Kit

Cell culture medium kit for robust generation of dorsal forebrain neural organoids from human pluripotent stem cells

Contact STEMCELL Technologies

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.

Challenges in Translating iPSC Technology

Related Multimedia

CRISPR-Cas9 Gene Editing of Cerebral Organoids to Model Microcephaly

Potential Applications of ALDH Bright Cells In Regenerative Medicine

Modeling Human Gastrointestinal Development and Disease Using Pluripotent Stem Cells

Item added to your cart

Explore Our Products

Contact STEMCELL Technologies